We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
-4.01%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$291M
AUM Growth
-$41.3M
Cap. Flow
-$11M
Cap. Flow %
-3.77%
Top 10 Hldgs %
76.43%
Holding
41
New
12
Increased
7
Reduced
18
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 42.56%
2 Technology 22.7%
3 Communication Services 12.24%
4 Financials 12.04%
5 Materials 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNR icon
1
RenaissanceRe
RNR
$13.3B
$27.6M 9.49%
202,827
-5,775
-3% -$740K
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
$27.3M 9.38%
517,829
-49,228
-9% -$2.96M
REGN icon
3
Regeneron Pharmaceuticals
REGN
$78.5B
$26.8M 9.2%
73,017
-114
-0.2% -$43.4K
UI icon
4
Ubiquiti
UI
$33.7B
$23.4M 8.04%
405,286
-5,135
-1% -$280K
PTC icon
5
PTC
PTC
$15.8B
$23M 7.91%
497,750
-11,013
-2% -$515K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$4.36T
$21M 7.21%
544,060
-13,340
-2% -$520K
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$19.7M 6.77%
161,202
+3,349
+2% +$410K
DMRC icon
8
Digimarc Corp
DMRC
$147M
$19.3M 6.61%
641,913
-9,965
-2% -$311K
MON
9
DELISTED
Monsanto Co
MON
$18.3M 6.29%
174,068
-1,055
-0.6% -$108K
NVO
10
Novo Nordisk
NVO
$208B
$16.1M 5.52%
896,136
-22,948
-2% -$416K
VNRX icon
11
VolitionRx Ltd
VNRX
$8.65M
$14.1M 4.83%
153,720
+7,345
+5% +$659K
PGEN icon
12
Precigen
PGEN
$2.24B
$10.8M 3.72%
449,511
-35,018
-7% -$975K
TTOO
13
DELISTED
T2 Biosystems, Inc
TTOO
$9.12M 3.13%
347
-29
-8% -$893K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.36T
$8.72M 3%
220,140
-2,680
-1% -$107K
MACK
15
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$6.21M 2.13%
193,513
-44,263
-19% -$1.89M
BIDU icon
16
Baidu
BIDU
$37.7B
$5.94M 2.04%
36,119
-17,460
-33% -$2.97M
ESGR
17
DELISTED
Enstar Group
ESGR
$3.92M 1.35%
19,828
+300
+2% +$55.2K
SNMX
18
DELISTED
Senomyx, Inc.
SNMX
$2.65M 0.91%
2,764,602
-2,085,060
-43% -$3.44M
TPL icon
19
Texas Pacific Land
TPL
$27.8B
$2.06M 0.71%
+62,352
New +$1.95M
MA icon
20
Mastercard
MA
$502B
$2.01M 0.69%
19,460
+1,525
+9% +$158K
BRK.A icon
21
Berkshire Hathaway Class A
BRK.A
$1.1T
$488K 0.17%
2
BRK.B icon
22
Berkshire Hathaway Class B
BRK.B
$1.1T
$394K 0.14%
2,415
+1,015
+73% +$156K
MSFT icon
23
Microsoft
MSFT
$3.45T
$384K 0.13%
+6,179
New +$372K
Y
24
DELISTED
Alleghany Corp
Y
$286K 0.1%
470
+200
+74% +$112K
KO icon
25
Coca-Cola
KO
$377B
$203K 0.07%
+4,900
New +$204K

Similar funds

Lagoda Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Lagoda Investment Management held 41 positions worth $291M, down 12% from $333M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Lagoda Investment Management withdrew a net $11M in Q4 2016, closing 1 position and reducing 18 holdings. Its most notable exit was GSK, an estimated $8K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Lagoda Investment Management opened a new position in Texas Pacific Land worth $2.06M.

  • Lagoda Investment Management's largest Q4 2016 buy was Texas Pacific Land: 62,352 shares worth $2.06M.
  • Lagoda Investment Management added most to VolitionRx Ltd in Q4 2016, an estimated $659K increase.
  • Lagoda Investment Management's biggest Q4 2016 reduction was Senomyx, Inc., cutting an estimated $3.44M.
  • Lagoda Investment Management fully exited GSK in Q4 2016, selling an estimated $8K.
  • Lagoda Investment Management's ten largest holdings make up 76% of its $291M portfolio in Q4 2016.
  • Lagoda Investment Management opened 12 new positions and closed 1 in Q4 2016.
  • Lagoda Investment Management's portfolio value fell 12% quarter-over-quarter to $291M.

Based on Lagoda Investment Management's 13F filing for Q4 2016, filed 24 Jan 2017.